The SNM has announcedthe formation of theMolecular Imaging ClinicalTrials Network, a multi-institutionaleffort to establishscientifically sound, efficientways to evaluate proposedclinical applicationsof biomarker imaging.
The SNM has announced the formation of the Molecular Imaging Clinical Trials Network, a multi-institutional effort to establish scientifically sound, efficient ways to evaluate proposed clinical applications of biomarker imaging.
The network will provide investigational new drugs to the pharma industry and to molecular imaging researchers to develop the next generation of diagnostic and therapeutic agents, according to SNM officials. It will also coordinate imaging protocols and equipment calibration for multicenter clinical trials.
Scientific investigation under the program should start in the first quarter of 2009.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.